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EpidemiologyAbstract Documented meningioma cases in Central Texas (USA) from 1976 to 2013
were studied utilizing the Scott & White Brain Tumor Registry. All the cases exam-
ined were histologically diagnosed as meningiomas. Of the 372 cases, most were
benign tumors (p < 0.05). A majority of the patients were females (p < 0.05). Elderly
individuals (>45 years of age) superseded the younger patients in meningioma inci-
dence (p < 0.05). Previous data regarding meningioma epidemiology in Texas
showed a higher incidence in black patients when compared to white patients. By
contrast, this study’s findings of Central Texas meningioma demographics show
increased incidence of meningiomas in white patients (p < 0.05). This interesting
find in meningioma prevalence warrants further investigation with a larger sample
size, in order to establish validity and further parse out possible causes of menin-
gioma development among white individuals.
 2016 Ministry of Health, Saudi Arabia, Production and hosting by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecom-
mons.org/licenses/by-nc-nd/4.0/).1. Introduction
Meningiomas are the most common primary brain
tumors in adults, constituting a third of all diag-
nosed primary neoplasms of the brain [1]. It has
been reported that the age-adjusted incidence rate
of meningioma is 7.61/100,000 individuals per year
[2]. Although most meningiomas are considered
histologically benign and many are clinically silent,
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have on society can be huge [3,4]. Many patients
diagnosed with a meningioma live with devastating
clinical symptoms that vary depending on the size
and location of the growth [4,5]. Symptoms
include, but are not limited to: vision loss, sei-
zures, neurological deficits, speech dysfunction,
difficulty in concentration, and motor weakness
to name several [4]. Additionally, open microsurgi-
cal resection (the treatment of choice for menin-
giomas) has the potential to induce morbidity in
and of itself, due to its complexity and time bur-
den, especially in older patients with preexisting
medical conditions. This is attributable to the
benign and slow-growing nature of most menin-
giomas, resulting in many patients developing of
large lesions over several years and thus requiring
more invasive procedures. These large resections
increase the risk of morbidity, particularly in older
individuals with preexisting conditions [6]. Yet,
despite its high prevalence rate and increased risk
of morbidity, relatively little knowledge exists in
the literature regarding the epidemiology of
meningiomas [7]. Only recently has the Senate
Appropriations Committee recognized this paucity
of knowledge and subsequently made recommen-
dations to increase attention on brain tumor
research.
Recent research has led to the discovery of pos-
sible genetic and environmental risk factors for
meningiomas. Genetically, it has been shown that
meningiomas are the secondmost frequently occur-
ring tumors in patients with neurofibromatosis type
II, and to a lesser degree, can occur in the setting of
multiple endocrine neoplasia type I [1].
Most nongenetic risk factors are environmental
and are associated with economic development.
To date, studies assessing the involvement of hair
dye, cell phone use, allergens, agricultural chemi-
cals, petrochemicals, rubber and solvent contacts,
loud noise, infection, passive and active smoke
exposure, and exogenous hormone use with menin-
gioma occurrence have given rise to inconclusive or
mixed results. By contrast, ionizing radiation expo-
sure has been proven to be a definite risk factor for
meningiomas, as well as for other lethal carcino-
mas [4,8].
The aim of this study is to undertake an analysis
of meningioma occurrence in the Central Texas
region (USA). Previous reports have alluded to the
presence of a relatively high amount of radiation
in Texas drinking water, specifically radium 226
and radium 228 [9,10]. Additionally, the Central
Texas region has seen a massive increase in eco-
nomic development over the past few decades.As a result, exposure to many of the risk factors
previously alluded to, such as exogenous hor-
mones, cell phones, hair dye, allergens, petro-
chemicals, agriculture, loud noise, and radiation,
have increased and are now widespread in Central
Texas at varying degrees [8–10]. According to a
2012 Centers for Disease Control and Prevention
(CDC) report, 27.7% of Texas residents were obese
(body mass index P30), thus increasing this
group’s risk of meningioma [11]. Therefore, the
data accrued will also facilitate the assessment of
the cumulative contribution of the aforementioned
possible environmental risk factors on the occur-
rence of meningioma. To achieve our objectives,
we evaluated cases from the Scott & White Health
Care Tumor Registry ranging from 1976 to 2013.
This study meets the Scott & White Health Care
Central Texas institutional review board (IRB)
guidelines, as well as those of the National Insti-
tutes of Health (NIH).
2. Materials and methods
Patient details were obtained from the Scott &
White Brain Tumor Registry which is a SW Temple,
Texas hospital-based tumor registry. Our data are
based on cerebral and spinal meningioma. For the
purposes of this study, meningioma diagnoses were
considered to be definitive when obtained through
surgical biopsy and/or resection. As such, 372 cases
in the tumor registry, ranging from 1976 to 2013,
which had undergone surgical procedures where
the final histological diagnoses were confirmed as
meningiomas, were examined. The data were
stratified according to sex, age group (0–19 years
of age, 20–34 years of age, 35–44 years of age,
45–54 years of age, 55–64 years of age, 65–
74 years of age, 75–84 years of age, > 85 years of
age), ethnicity (white, black, Hispanic), and histol-
ogy (benign or malignant). Factorial analysis of
variance was utilized (general linear models; Sta-
tistica version 8.0, Statsoft – Tulsa, OK, USA). Post
hoc assessments were conducted with the Duncan’s
multiple range tests and a p value <0.05 qualified
as statistically significant.
3. Results
3.1. Age group
Five of the eight age groups were compared with
each other (0–19 years, 20–34 years, 35–44 years,
45–54 years, 55–64 years, 65–74 years, 75–
84 years, >85 years). The number of patients
between the ages of 45 years and 84 years (84%)
Fig. 1 Patient demographics divided by age groups.
Fig. 3 Patient demographics as determined by race.
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than 85 years (F7, 21 = 7.8, p = 0.001, Fig. 1).
3.2. Sex
Of the 372 cases, 262 were female (70.4%,
F1, 21 = 18.1, p = 4  104, Fig. 2).
3.3. Ethnicity
A total of 286 (76.9%) patients were white (and
non-Hispanics), 44 (11.8%) patients were black
(and non-Hispanics), 23 (6.2%) patients were His-
panic, and 19 (5.1%) patients were classified asFig. 2 Patient demographics as determined by sex.other (Fig. 3). The four groups were analyzed and
white patients were more numerous than the
others (F3, 21 = 56.2, p = 3.3  10–10).
3.4. Histology
Meningiomas are meningothelial (arachnoidal) cell
neoplasms that are typically attached to the inner
surface of the dura mater. According to the World
Health Organization (WHO), most meningiomas are
benign and correspond to the WHO Grade I classifi-
cation [12]. Certain histological subtypes are asso-
ciated with less favorable clinical outcomes and
correspond to WHO Grade II (atypical) and Grade
III (anaplastic or malignant). Meningiomas display
an extremely diverse microscopic appearance with
numerous histologic variants. The prototypical
meningioma is that of a spindle cell tumor arranged
in a whorled or lobulated architecture. The neo-
plastic cells have a meningothelial appearance
with round-to-oval nuclei, inconspicuous nucleoli,
and eosinophilic cytoplasm. Psammoma bodies
are often noted throughout the tumor. The vast
majority of meningiomas stain for epithelial mem-
brane antigen. In order to be characterized as an
anaplastic (malignant) meningioma, there must
be obviously malignant cytology resembling that
of carcinoma, melanoma or high-grade sarcoma,
or a markedly elevated mitotic index (20 or more
mitoses per 10 high-power fields) [12]. Invasion of
the brain alone is not sufficient for a diagnosis of
anaplastic (malignant) meningioma.
Out of the 372 cases, 358 (96%) were diagnosed
as benign meningiomas (WHO Grade I and Grade II),
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cies (WHO Grade III). The number of benign tumors
was more than the malignant tumors (F1, 21 = 92.6,
p = 3.76  109, Fig. 6).
3.5. Patient distribution of ethnically white
patients
Patient distribution within the white population
followed the demographics of the rest of the
population. Most of the tumors were histologi-
cally benign (2.4% vs. 97.6%, Fig. 6). There were
more female patients than male patients (29% vs.
71%, Fig. 5). The ages of 84% of the patients
were between 45 years and 84 years (Fig. 4).Fig. 4 Distribution of white patients according to age.
Fig. 5 Distribution of white patients according to sex.
Fig. 6 Distribution of tumors according to histological
grade.4. Discussion
Our study is unique as we compared only histolog-
ically confirmed meningiomas. The disadvantage
of this is the inability to compare these findings
with existing epidemiological findings related to
meningiomas and draw final conclusions. Most of
the existing studies consider meningiomas con-
firmed by histology and radiological diagnostic
methods. However, theoretically, these compar-
isons should be valid. It has been shown on many
occasions that radiological accuracy of menin-
gioma diagnosis is near perfect [13]. Having said
that, authors acknowledge that this can be a con-
founding factor in this study.
The incidence of meningiomas among females is
shown to be 2.3 times that of males, nationally.
The Central Texas trend that we saw mirrors that
of the nation, with over two-thirds (70.4%) of
patients being female. Incidence in the United
States (U.S.) also increases with age, with a much
steeper increase occurring after the age of
65 years. Thus, elderly individuals are more likely
to be diagnosed with meningiomas when compared
to younger populations, especially at the seventh
and eighth decades of life. The Central Texas trend
follows that of the national population, with older
individuals (P45 years) more likely to be diagnosed
with meningiomas. Additionally, this study found
that Central Texas meningiomas are more likely
to be benign, also following the national
patterns [2].
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that the age-adjusted incidence rates of menin-
giomas are significantly higher among the black
population, with an incidence rate ratio (white:
black) of 0.8 for nonmalignant meningiomas and
0.7 for malignancies [2]. Our data reveal a stark
opposing trend in the Central Texas region, with
83.1% of cases arising in white individuals (exclud-
ing Hispanics/Latinos) despite the fact that the
demographic stratification of the U.S. and Central
Texas (Bastrop, Bell, Burnet, Caldwell, Hays, Tra-
vis, and Williamson counties) populations accord-
ing to the U.S. Census Bureau’s 2013 American
Community Survey appears to be similar. Some
31.9% of the Central Texas population isP45 years
of age, 79.6% identified themselves as white (race
alone or in combination with 1 or more other races,
including Hispanic/Latino), 10.5% identified them-
selves as black/African-American, and 49.9% are
female. The overall U.S. population aged
P45 years is 40.5%, with 76.2% identifying them-
selves as white (race alone or in combination with
1 or more other races, including Hispanic/Latino)
and 13.8% as black/African American; 50.8% of
the U.S. population is female [14]. Based on these
data, it seems that differences in demographic dis-
tribution between Central Texas and the rest of the
nation may not be a contributing factor for the
increased meningioma prevalence in the Central
Texas white population. However, further investi-
gation and analysis is required to assess if there
are indeed any significant differences between
Central Texas and the U.S. as a whole with regard
to population demographics, in order to provide a
more decisive answer.
Discrepancies in healthcare access may provide
insight as to the higher incidence of meningiomas
in the Central Texas white population. Previous
studies have found that African-Americans are
more likely to be without insurance and a usual
source of healthcare than white individuals [15].
In 2011, the average proportion of black individuals
reporting barriers to access of care nationwide was
29% compared with 23% among white individu-
als [16]. Thus, it is possible that our findings
regarding meningioma prevalence when stratified
by race may be confounded due to an increased
ability for white individuals to access various forms
of healthcare. There is an abundance of data dis-
cussing healthcare access disparities among minor-
ity groups in the U.S. and further investigation into
the possibility of such disparities existing in the
Central Texas region are warranted in order to
assess its possible contribution as a confounder to
the findings of this study.Differences in occupational exposure may also
provide insight into discrepancies of meningioma
incidence between racial groups. It is possible that
white individuals in Central Texas face increased
occupational exposure to meningioma risk factors.
Many of these factors are associated with indus-
trial, construction, and materials transport occu-
pations. Nationally, black men are more likely
than white men to work in production, transporta-
tion, and material moving occupations, and white
men are more numerous than black men in the con-
struction industry [17]. Central Texas may yield a
different workforce distribution, which may
account for the prevalence divergence when com-
pared to national meningioma statistics. Further
investigation into the distribution of the Central
Texas workforce is needed to ascertain discrepan-
cies in risk factor exposures between white and
black laborers.
Studies have reported that >50% of patients with
meningioma experience impaired cognition and
worse quality of life [3,18]. It has also been found
that approximately a third of patients diagnosed
with benign meningiomas had stable or worse neu-
rological symptoms following surgery, two-thirds
suffered long-term neurological sequelae, and a
quarter were chronically disabled [5]. Other stud-
ies have shown that preexisting conditions such as
hypertension, diabetes mellitus, and epilepsy may
contribute to meningioma development and pro-
gression [6,18–21]. While the findings of this study
revealed that relatively older (P45 years) individu-
als are more likely to be diagnosed with menin-
giomas, a younger patient demographic was
diagnosed with meningiomas based on the cases
isolated from the Scott & White Tumor Registry rel-
ative to the national statistics cutoff of 65 years.
This is cause for concern, since it could indicate
that individuals in Central Texas may suffer from
the comorbidities and complications associated
with meningiomas starting at an earlier age, and
thus incurring a prolonged reduction in quality of
life, or shortening lifespan altogether. Coupled
with the increased prevalence of potential menin-
gioma risk factors in Central Texas that were dis-
cussed earlier, it is plausible to postulate that
individuals in the region are now at increased sus-
ceptibility to meningiomas and associated debili-
tating morbidities at a younger age than the rest
of the nation. This warrants further investigation
in greater detail.
In addition to the main shortcoming explained in
the first chapter, we acknowledge several other
drawbacks in our study design. It is common
practice for physicians and patients to pursue
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[22,23]. Since only meningioma patients who were
subjected to surgery were included in the study,
this could explain why we found an increased
prevalence of meningiomas in a younger demo-
graphic and thus be a confounding factor.
Improved diagnostic methods can be a confounding
factor at any setting when considering overdiagno-
sis and unnecessary aggressive treatment. Also,
this study does not consider patients who sought
other methods of treatment, such as radiotherapy,
endovascular procedures, or conservative
approaches. Many of the risk factors mentioned
related to Central Texas are not well validated,
and the sample from which incidence was calcu-
lated may not be representative of the region at
large, due to being a hospital-based small sample.
However, these findings should encourage subse-
quent larger scale investigations on a more exten-
sive patient pool, in order to achieve a greater
sample size. We anticipate these findings will
encourage more controlled studies in this demo-
graphic area.
5. Conclusions
A relatively younger (<45 years of age) population
was diagnosed with meningiomas in Central Texas
compared to national statistics. Additionally,
non-Hispanic white individuals appear to be at
greater risk for developing meningiomas than
black individuals, which is in stark contrast to
the national trend. However, the mean survival
rate between the elderly and younger groups
failed to become statistically significant. In order
to confirm whether these observations are due to
confounding factors in our study design or due to
environmental and occupational risk factors, as
well as to assess the effects of increased possible
meningioma risk factors on the Central Texas
population, further detailed investigation is
needed.
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